FDA
approval
· 2023-02-08
FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
The FDA approved a supplemental application for a generic inhaled fixed-dose combination of fluticasone propionate and salmeterol by Hikma Pharmaceuticals USA I…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FLUTICASONE PROPIONATE AND SALMETEROL (FLUTICASONE PROPIONATE AND SALMETEROL)